logo
logo

Abozymes Completes Seed Financing Round To Fund Development Of Technology To Enable Universal Organ Transplants And Blood Transfusions

Jun 23, 2022about 3 years ago

Round Type

seed

Vancouver

Description

ABOzymes Biomedical Inc., today announced it has completed a substantially upsized seed financing. The funds will be used to further develop its ground-breaking proprietary platform that enables a world where a patient’s blood type is no longer the first constraint when they need life-saving organ transplants or blood transfusions.

Company Information

Company

Ab Ozymes

Location

Vancouver, Washington, United States

About

www.abozymes.com

FundzWatch™ Score

72
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood